Jump to content

CK7 positive, TTF-1 positive & Napsin-A/P40 negative


Recommended Posts

I have not heard of these mutations however that’s not unusual.  The molecular testing results reveal a large number of mutations identified, in fact there are hundreds, however it may not have any impact on the development of a precision treatment plan. To date, there are about 9 mutations that will respond to targeted therapy which is what the oncologist is looking for. 
So then why bother testing for all known mutations? The science is moving pretty fast so it’s better to know as clinical trials emerge it could open the door to additional treatment options.  

What did the oncologist say about it?  Just curious.  

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.